Is Avrobio Inc (AVRO) a Stock to Watch After Losing -19.55% This Week?

Avrobio Inc (AVRO) stock is lower by 19.55% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Avrobio Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AVRO!

See Full AVRO Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With AVRO Stock Today?

Avrobio Inc (AVRO) stock is trading at $1.07 as of 9:35 AM on Tuesday, Jan 30, a loss of -$0.30, or -21.9% from the previous closing price of $1.37. The stock has traded between $1.01 and $1.14 so far today. Volume today is above average. So far 238,023 shares have traded compared to average volume of 157,220 shares.

More About Avrobio Inc

Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Click Here to get the full Stock Report for Avrobio Inc stock.